Review showing the utility of Adalimumab (monoclonal antibody anti-TNF) in management of immune-mediated inflammatory diseases
Adalimumab in the treatment of immune-mediated diseases / Lapadula G; Marchesoni A; Armuzzi A; Blandizzi C; Caporali R; Chimenti S; Cimaz R; Cimino L; Gionchetti P; Girolomoni G; Lionetti P; Marcellusi A; Mennini FS; Salvarani C. - In: INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY. - ISSN 0394-6320. - STAMPA. - 27:(2014), pp. 33-48. [10.1177/03946320140270S103]
Adalimumab in the treatment of immune-mediated diseases
CIMAZ, ROLANDO;LIONETTI, PAOLO;
2014
Abstract
Review showing the utility of Adalimumab (monoclonal antibody anti-TNF) in management of immune-mediated inflammatory diseases
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
